Canada is suspending the use of the Oxford-AstraZeneca coronavirus vaccine for people under age 55 following concerns it may be linked to rare blood clots.

TORONTO (AP) — Canada on Monday suspended the use of the Oxford-AstraZeneca coronavirus vaccine for people under age 55 following concerns it might be linked to rare blood clots.

The National Advisory Committee on Immunization had recommended the pause for safety reasons and the Canadian provinces, which administer health in the country, announced the suspension Monday.

READ  IRS Struggles to Hire Customer Service Reps as People Choose Unemployment Over Working for IRS

“There is substantial uncertainty about the benefit of providing AstraZeneca Covid-19 vaccines to adults under 55 given the potential risks,” said Dr. Shelley Deeks, vice chair of the National Advisory Committee on Immunization.

READ  Visualizing One Year of Fluctuating Covid-19 Vaccine Stock Prices

Deeks said the updated recommendations come amid new data from Europe that suggests the risk of blood clots is now potentially as high as one in 100,000, much higher than the one in one million risk believed before.

www.usnews.com/news/world/articles/2021-03-29/canadian-panel-recommends-astrazeneca-pause-for-under-55

573 views

Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.